This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Veronica Kinsler is a British physician scientist specialising in paediatric dermatology and molecular genetics.[1] She is Professor of Paediatric Dermatology and Dermatogenetics at the Great Ormond Street Hospital for Children (GOSH) and the University College London GOS Institute of Child Health.[2]
Veronica Anne Kinsler | |
|---|---|
 | |
| Born | Scotland, UK |
| Alma mater | University of Cambridge, University College London |
| Scientific career | |
| Fields | Paediatric Dermatology, Molecular Genetics, Precision Medicine |
| Institutions | Francis Crick Institute
University College London Great Ormond Street Hospital |
| Website | https://www.crick.ac.uk/research/find-a-researcher/veronica-kinsler |
Education and career
editKinsler studied Medical Sciences and Clinical Medicine at the University of Cambridge, and completed a PhD in Molecular Genetics at the University College London.[3] She also received training in paediatric dermatology.[2]
Kinsler works both in clinical practice and as a researcher.[4] She is a professor of Paediatric Dermatology and Dermatogenetics at the Great Ormond Street Hospital for Children (GOSH) and the University College London GOS Institute of Child Health.[2] She also works as the Principal Group Leader and Assistant Research Director at the Francis Crick Institute in London.[3] She was the president of the European Society of Pediatric Dermatology between 2020 and 2022.[5] She is the senior editor of Harper's Textbook of Pediatric Dermatology.[3] In 2021 she was awarded a Research Professorship by the National Institute for Health and Care Research (NIHR).[6] She is a Fellow of the Royal College of Paediatrics and Child Health.[7]
Research
editHer research focuses on children's skin diseases, including rare and genetic conditions, mosaicism, and diseases that can result in cancer.[4][8] Her research led to the discovery of the genetic causes of multiple rare diseases, including congenital melanocytic naevus syndrome[4][9] and arteriovenous malformations.[10][11] Her research explores novel therapeutic approaches for currently incurable diseases.[4][12]
References
edit- ^ "Veronica Kinsler". scholar.google.com. Retrieved 2024-02-02.
- ^ a b c "Veronica Kinsler MA MB BChir FRCPCH PhD". GOSH Hospital site. Retrieved 2024-02-02.
- ^ a b c "Veronica Kinsler". Crick. 2024-06-01. Retrieved 2024-02-02.
- ^ a b c d Kinsler, Veronica A. (2024-06-01). "Piecing together the mosaic of rare skin diseases: an interview with Veronica Kinsler". Disease Models & Mechanisms. 17 (6). doi:10.1242/dmm.050636. ISSN 1754-8403. PMC 10820732. PMID 38235593.
- ^ "History". European Society for Paediatric Dermatology. Retrieved 2024-02-03.
- ^ "Current NIHR Research Professors". www.nihr.ac.uk. Retrieved 2024-02-02.
- ^ "Veronica Kinsler". University College London. Retrieved 2024-02-03.
- ^ "Lecturers". Paediatric Dermatology Courses. Retrieved 2024-02-03.
- ^ Kinsler, Veronica A.; Thomas, Anna C.; Ishida, Miho; Bulstrode, Neil W.; Loughlin, Sam; Hing, Sandra; Chalker, Jane; McKenzie, Kathryn; Abu-Amero, Sayeda; Slater, Olga; Chanudet, Estelle; Palmer, Rodger; Morrogh, Deborah; Stanier, Philip; Healy, Eugene (September 2013). "Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS". Journal of Investigative Dermatology. 133 (9): 2229–2236. doi:10.1038/jid.2013.70. PMC 3678977. PMID 23392294.
- ^ "Cancer drugs could treat rare blood-vessel disorder". 2018-02-20. Retrieved 2024-02-03.
- ^ Al-Olabi, Lara; Polubothu, Satyamaanasa; Dowsett, Katherine; Andrews, Katrina A.; Stadnik, Paulina; Joseph, Agnel P.; Knox, Rachel; Pittman, Alan; Clark, Graeme; Baird, William; Bulstrode, Neil; Glover, Mary; Gordon, Kristiana; Hargrave, Darren; Huson, Susan M. (2018-11-01). "Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy". Journal of Clinical Investigation. 128 (11): 5185. doi:10.1172/JCI124649. ISSN 0021-9738. PMC 6205386. PMID 30382944.
- ^ "Breakthrough means painful, giant moles that develop in rare condition CMN could be reversed". Sky News. Retrieved 2024-11-03.
External links
edit